Baseline shift corrections towards the heart: External validation of the impact on survival in early-stage NSCLC patients

被引:1
|
作者
Juan-Cruz, Celia [1 ]
Stam, Barbara [1 ]
Rossi, Maddalena [1 ]
Belderbos, Jose [1 ]
Sonke, Jan-Jakob [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
关键词
NSCLC; SBRT; Baseline shifts; Deformable image registration; Heart dose; STEREOTACTIC BODY RADIOTHERAPY; LUNG-CANCER PATIENTS; RADIATION-THERAPY; ANATOMICAL CHANGES; CARDIAC TOXICITY; PREDICTOR; TRIALS; ERRORS; INTRA;
D O I
10.1016/j.radonc.2024.110214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To externally validate Johnson-Hart et al. findings: the association of tumor baseline shifts towards the heart with overall survival (OS) in SBRT for NSCLC. Further analysis included investigating the presence of interfractional heart baseline shifts and the association of OS with heart dose change during treatment. Methods: Data from 416 SBRT early-stage NSCLC patients was collected. Pearson's correlations (PCCs) between clinical variables and treatment-averaged tumor shifts towards/away from the heart were explored. Validation of published multivariable Cox model was performed. PCCs between heart and tumor baseline shifts were analyzed. Dose accumulation was performed following daily CBCT-to-pCT deformable registration. Maximum heart dose (D-0) was computed for planned and accumulated doses. Differences in OS according to shifts towards/away from the heart or D-0 increase/decrease were analyzed. Significant D-0 differences between patients with D-0 increase/ decrease and different tumor locations were explored. Results: Tumor shifts towards/away from the heart showed no significant association with OS (p = 0.91). Distance between PTV and heart correlated significantly (PCC = 0.18) with shifts to the heart. Cox model did not validate in our cohort. Heart presented baseline shifts positively correlated with tumor baseline shifts in all three directions (PCC >= 0.38; p < 0.001). Counterintuitively, patients experiencing increased D0 0 during treatment showed significantly better OS (p = 0.0077). Upper-lobe tumor patients with increased D0 0 had lower D0 0 than those with decreased D0 0 (right-upper-lobe p <= 0.018). Conclusions: In our SBRT cohort, the shifts towards the heart were not associated with worse OS. Moderate correlations were found between tumor and heart baseline shifts in each direction. Moreover, the distance between the PTV and the heart showed a significant correlation with shifts to the heart.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort
    Zhang, Hao
    Zeng, Jingtong
    Li, Xianjie
    Zhang, Bo
    Wang, Hanqing
    Tang, Quanying
    Zhang, Yifan
    Bao, Shihao
    Zu, Lingling
    Xu, Xiaohong
    Xu, Song
    Song, Zuoqing
    CANCER MEDICINE, 2024, 13 (01):
  • [2] New predictors of survival for early-stage NSCLC
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2007, 8 (04): : 288 - 288
  • [3] EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients
    Mederer, Tobias
    Elsner, Felix
    Robold, Tobias
    Grosser, Christian
    Neu, Reiner
    Ried, Michael
    Bleicher, Sabine
    Schamberger, Thomas
    Blochberger, Isabell
    Hofmann, Hans-Stefan
    Klein, Christoph A.
    LUNG CANCER, 2022, 167 : 73 - 77
  • [4] Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients
    Miranda, Keila Cristina
    Siqueira, Alexia Polo
    Santiago Goncalves, Maria Fernanda
    Tegami, Isabella Lemuqui
    Pinto, Icaro Alves
    De Marchi, Pedro
    Dias, Josiane Mourao
    Santana, Iara Vidigal
    Silva, Vinicius Duval
    Batah, Sabrina Setembre
    Zimermam, Heloisa Acurcio
    Fabro, Alexandre Todorovic
    Souto-Moura, Conceicao
    Guimaraes, Susana
    Carneiro, Fatima
    Freitas, Claudia
    Bastos, Helder Novais E.
    Da Silva, Luciane Sussuchi
    Reis, Rui Manuel
    Leal, Leticia Ferro
    Reis, Rui
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC
    Moreno, Amy C.
    Fellman, Bryan
    Hobbs, Brian P.
    Liao, Zhongxing
    Gomez, Daniel R.
    Chen, Aileen
    Hahn, Stephen M.
    Chang, Joe Y.
    Lin, Steven H.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (01) : 101 - 109
  • [6] Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
    Xintao Wang
    Wenpei Shi
    Xiaowen Pu
    Yan Hu
    Ruiying Chen
    Haiyan Zhu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13727 - 13739
  • [7] Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
    Wang, Xintao
    Shi, Wenpei
    Pu, Xiaowen
    Hu, Yan
    Chen, Ruiying
    Zhu, Haiyan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (15) : 13727 - 13739
  • [8] Baseline radiomic features for outcome modeling in early-stage NSCLC candidates to SBRT
    Volpe, Stefania
    Gaeta, Aurora
    Casbarra, Alessia
    Franzetti, Jessica
    Camarda, Anna M.
    Mastroleo, Federico
    Piperno, Gaia
    Zaffaroni, Mattia
    Vincini, Maria G.
    Raimondi, Sara
    Botta, Francesca
    Isaksson, Lars J.
    Gandini, Sara
    Cremonesi, Marta
    Orecchia, Roberto
    Jereczek-Fossa, Barbara A.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1661 - S1663
  • [9] Pleural Contact in Clinical Early-Stage NSCLC: Recurrence Patterns and Survival
    Feinstein, S.
    Usera, B. M.
    Ahmed, A.
    Aldin, M. A. Kamal
    Daly, M. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E372 - E373
  • [10] Improving Survival for Patients With Early-Stage Melanoma
    Maher, Ian A.
    JAMA DERMATOLOGY, 2019, 155 (11) : 1229 - 1230